Yu Fan reported 7 positions worth $103.58M for the quarter ended Jun 30, 2026, up 11.6% on the prior quarter. It opened 0 new positions, added to 1, trimmed 2 and exited 0. Its largest holding is Kestra Medical Technologies, Ltd. at 56.1% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| WHWK Whitehawk Therapeutics, Inc. | +2.79M | +134.8% | $12.78M | 21.5% |
No new positions this quarter.
No positions were closed this quarter.
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | KMTS Kestra Medical Technologies, Ltd. | Healthcare | 2.28M | $58.07M | 56.06% | 0 | 0.0% | Unchanged | 3.91% |
| 2 | WHWK Whitehawk Therapeutics, Inc. | Healthcare | 4.86M | $22.26M | 21.5% | +2.79M | +134.8% | Added | 5.87% |
| 3 | ALMS Alumis Inc. | Healthcare | 252.7K | $7.11M | 6.86% | -524.2K | -67.5% | Reduced | 0.2% |
| 4 | CBLL Ceribell, Inc. | Healthcare | 342.4K | $6.66M | 6.43% | -207.1K | -37.7% | Reduced | 0.9% |
| 5 | IVA Inventiva S.A. | Healthcare | 1.50M | $5.67M | 5.47% | 0 | 0.0% | Unchanged | 0.8% |
| 6 | CATX Perspective Therapeutics, Inc. | Healthcare | 1.06M | $3.60M | 3.47% | 0 | 0.0% | Unchanged | 0.87% |
| 7 | ABTC American Bitcoin Corp. | Technology | 20.5K | $209.83K | 0.203% | 0 | 0.0% | Unchanged | 0.03% |
Tip. Select a row to see that position’s full history at Yu Fan.
As of its Q2 2026 13F filing, Yu Fan’s five largest positions were Kestra Medical Technologies, Ltd. (KMTS) at 56.1%, Whitehawk Therapeutics, Inc. (WHWK) at 21.5%, Alumis Inc. (ALMS) at 6.9%, Ceribell, Inc. (CBLL) at 6.4%, Inventiva S.A. (IVA) at 5.5% of the reported portfolio.
Yu Fan reported a 13F portfolio worth $103.58M across 7 positions for Q2 2026. That is up 11.6% from the previous quarter.
Its largest purchases by value were Whitehawk Therapeutics, Inc. ($12.78M). It opened 0 new positions.
Its largest sales by value were Alumis Inc. ($14.75M), Ceribell, Inc. ($4.03M). It exited 0 positions entirely.
From the Form 13F-HR reports Yu Fan files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.